Roche extends Spark offer after getting 29 percent in tender

Roche Holding has extended until May 2 its $4.3 billion offer for U.S. gene therapy specialist Spark Therapeutics, the Swiss drugmaker said after getting 29.4 percent of Spark’s shares in a tender originally due to end on Wednesday.

…read more

Read more here: Roche extends Spark offer after getting 29 percent in tender

Category: businessNews

Leave a Reply

%d bloggers like this: